Response to Letter to the Editor on "Rivaroxaban Use for Thromboprophylaxis Is Associated With Early Periprosthetic Joint Infection"
- PMID: 27341972
- DOI: 10.1016/j.arth.2016.05.017
Response to Letter to the Editor on "Rivaroxaban Use for Thromboprophylaxis Is Associated With Early Periprosthetic Joint Infection"
Comment on
-
Letter to the Editor on "Rivaroxaban Use for Thrombosis Prophylaxis is Associated With Early Periprosthetic Joint Infection".J Arthroplasty. 2016 Sep;31(9):2079. doi: 10.1016/j.arth.2016.05.018. Epub 2016 May 18. J Arthroplasty. 2016. PMID: 27329579 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical